Nanjing Hicin Pharmaceutical Co (SZSE:300584) YoY EPS Growth : 12.61% (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Nanjing Hicin Pharmaceutical Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Nanjing Hicin Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Mar. 2025 was 12.61%.

Nanjing Hicin Pharmaceutical Co's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was ¥0.13.

Nanjing Hicin Pharmaceutical Co YoY EPS Growth Historical Data

The historical data trend for Nanjing Hicin Pharmaceutical Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Hicin Pharmaceutical Co YoY EPS Growth Chart

Nanjing Hicin Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EPS Growth

Get a 7-Day Free Trial

-43.28

417.83

-88.66

12.22

10.56

Nanjing Hicin Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EPS Growth	Get a 7-Day Free Trial															8.82	55.74	12.00	-12.93	12.61

Nanjing Hicin Pharmaceutical Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Nanjing Hicin Pharmaceutical Co's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (A: Dec. 2024 )
=	(Earnings per Share (Diluted) (A: Dec. 2024 )	-	Earnings per Share (Diluted) (A: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2023 ) \|
=	(0.335	-	0.303)	/	\| 0.303 \|
=	10.56 %

Nanjing Hicin Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EPS Growth (Q: Mar. 2025 )
=	(Earnings per Share (Diluted) (Q: Mar. 2025 )	-	Earnings per Share (Diluted) (Q: Mar. 2024 ))	/	\| Earnings per Share (Diluted) (Q: Mar. 2024 )) \|
=	(0.125	-	0.111)	/	\| 0.111 \|
=	12.61 %

Nanjing Hicin Pharmaceutical Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Nanjing Hicin Pharmaceutical Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Hicin Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Hicin Pharmaceutical Co Ltd (SZSE:300584) » Definitions » YoY EPS Growth

Traded in Other Exchanges

N/A

Address

Heng Road 1, Nanjing Economic and Technological Development Zone, Jiangsu Province, Nanjing, CHN, 210009

Website

http://www.hicin.cn

Nanjing Hicin Pharmaceutical Co Ltd is a China-based company engaged in producing pharmaceutical preparations. In addition, it is also involved in manufacturing synthetic chemicals, conducting new drug research and development as well as technical transferring. The company produces series of the medicines such as antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for the cardio-cerebral system and immuno-modulate agents. The active pharmaceutical ingredients, omeprazole sodium for injection, cefepime hydrochloride for Injection and lansoprazole tablets are exported by the firm into South-Asian countries, South-American countries and European countries.

Executives

Cao Yu Ping	Directors, executives
Yan Mei Qiang	Directors, executives
Jiang Xiang Ming	Executives
Gu Hai	Independent director

Nanjing Hicin Pharmaceutical Co Headlines

No Headlines